A newly forged collaboration between WellSpan Health and the Maryland Proton Treatment Center (MPTC) is expanding South Central Pennsylvanians’ access to the latest in tissue-sparing, precision cancer care technology — proton therapy — while leveraging the expertise of providers from both entities.
WellSpan Health’s nationally recognized oncology clinical research program is at the forefront of emerging cancer therapies, extending additional options and a continued sense of hope to patients for whom standard treatments do not perform as anticipated.
Specialists at WellSpan Gynecologic Oncology unite multidisciplinary expertise with leading-edge surgical techniques to provide additional treatment options that improve cancer patients’ survival rates and quality of life.
To meet the challenges of the diabetes epidemic head-on, WellSpan Health incorporates evidence-based protocols, patient engagement, multidisciplinary care and ongoing education for providers.
Pairing telestroke technology with providers who have advanced training and an unusual breadth of experience, WellSpan Health’s four Joint Commission-certified Primary Stroke Centers expedite lifesaving, 24/7 care to patients across York, Adams, Lancaster and Lebanon counties.